Bayer's Q1 Operating Profit Surges 9%, Beating Forecasts on Strong Agribusiness Performance

Deep News05-12

German chemical and pharmaceutical giant Bayer reported on May 12 that its first-quarter operating profit rose 9% year-on-year, significantly exceeding market expectations, driven by strong performance in its agricultural business, particularly from soybean seed revenues.

Financial data shows that Bayer's EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization), excluding special items, reached 4.45 billion euros (approximately $5.23 billion) for the first quarter. This figure is notably higher than the company's official compilation of average analyst estimates, which was 3.93 billion euros.

Among the segments, the Crop Science business performed exceptionally well, with profits soaring 17.9% year-on-year to 3 billion euros. Analysis indicates that, in addition to market demand, the resolution of a soybean licensing dispute with its main competitor Corteva earlier this year provided significant support for the segment's profit growth.

Alongside the earnings release, Bayer reaffirmed its currency-adjusted performance guidance for 2026, expressing confidence in achieving its full-year operational targets.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1156375827?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-12 14:12","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1156375827","market":"us","top_or_hot":-1,"title":"Bayer's Q1 Operating Profit Surges 9%, Beating Forecasts on Strong Agribusiness Performance","media":"Deep News","content":"<p>German chemical and pharmaceutical giant Bayer reported on May 12 that its first-quarter operating profit rose 9% year-on-year, significantly exceeding market expectations, driven by strong performance in its agricultural business, particularly from soybean seed revenues.</p>\n<p>Financial data shows that Bayer's EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization), excluding special items, reached 4.45 billion euros (approximately $5.23 billion) for the first quarter. This figure is notably higher than the company's official compilation of average analyst estimates, which was 3.93 billion euros.</p>\n<p>Among the segments, the Crop Science business performed exceptionally well, with profits soaring 17.9% year-on-year to 3 billion euros. Analysis indicates that, in addition to market demand, the resolution of a soybean licensing dispute with its main competitor Corteva earlier this year provided significant support for the segment's profit growth.</p>\n<p>Alongside the earnings release, Bayer reaffirmed its currency-adjusted performance guidance for 2026, expressing confidence in achieving its full-year operational targets.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bayer's Q1 Operating Profit Surges 9%, Beating Forecasts on Strong Agribusiness Performance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBayer's Q1 Operating Profit Surges 9%, Beating Forecasts on Strong Agribusiness Performance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1039043262\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Deep News </p>\n<p class=\"h-time\">2026-05-12 14:12</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>German chemical and pharmaceutical giant Bayer reported on May 12 that its first-quarter operating profit rose 9% year-on-year, significantly exceeding market expectations, driven by strong performance in its agricultural business, particularly from soybean seed revenues.</p>\n<p>Financial data shows that Bayer's EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization), excluding special items, reached 4.45 billion euros (approximately $5.23 billion) for the first quarter. This figure is notably higher than the company's official compilation of average analyst estimates, which was 3.93 billion euros.</p>\n<p>Among the segments, the Crop Science business performed exceptionally well, with profits soaring 17.9% year-on-year to 3 billion euros. Analysis indicates that, in addition to market demand, the resolution of a soybean licensing dispute with its main competitor Corteva earlier this year provided significant support for the segment's profit growth.</p>\n<p>Alongside the earnings release, Bayer reaffirmed its currency-adjusted performance guidance for 2026, expressing confidence in achieving its full-year operational targets.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"FT_SY_ZS","symbol_name":"大豆","start_time":0,"source_url":"","article_id":"1156375827","we_media_id":"1039043262","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1156375827","pubTimestamp":1778566330,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Deep News","introduction":"Global Stock Market Deep Analysis","home_visible":1,"id":"1039043262","head_image":"https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922"},"summary":"German chemical and pharmaceutical giant Bayer reported on May 12 that its first-quarter operating profit rose 9% year-on-year, significantly exceeding market expectations, driven by strong...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"SOYB.UK":"大豆ETF","EUO":"欧元ETF-ProShares两倍做空"},"translate_title":"拜耳第一季度营业利润飙升9%，农业企业业绩强劲，超出预期","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EUO":1,"XKmain":1,"ZSmain":1,"SOYB.UK":1,"EURmain":1},"content_text":"German chemical and pharmaceutical giant Bayer reported on May 12 that its first-quarter operating profit rose 9% year-on-year, significantly exceeding market expectations, driven by strong performance in its agricultural business, particularly from soybean seed revenues.\nFinancial data shows that Bayer's EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization), excluding special items, reached 4.45 billion euros (approximately $5.23 billion) for the first quarter. This figure is notably higher than the company's official compilation of average analyst estimates, which was 3.93 billion euros.\nAmong the segments, the Crop Science business performed exceptionally well, with profits soaring 17.9% year-on-year to 3 billion euros. Analysis indicates that, in addition to market demand, the resolution of a soybean licensing dispute with its main competitor Corteva earlier this year provided significant support for the segment's profit growth.\nAlongside the earnings release, Bayer reaffirmed its currency-adjusted performance guidance for 2026, expressing confidence in achieving its full-year operational targets.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.3","shortVersion":"4.42.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1156375827","isCrawlerRequest":true}